Related Experiment Videos
Xeroderma pigmentosum group A correcting protein from calf thymus
A P Eker1, W Vermeulen, N Miura
1MGC-Department of Cell Biology and Genetics, Erasmus University Rotterdam, The Netherlands.
Mutation Research
|September 1, 1992
Summary
Researchers purified a protein that corrects DNA repair defects in xeroderma pigmentosum complementation group A (XP-A) cells. This stable, 41 kD protein shows DNA binding and is related to the human XP-A gene product.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Xeroderma pigmentosum (XP) is a genetic disorder characterized by defective DNA repair.
- XP complementation group A (XP-A) cells exhibit a specific defect in nucleotide excision repair (NER).
Purpose of the Study:
- To purify and characterize a protein factor that can correct the DNA repair defect in XP-A cells.
- To investigate the properties and identify the active component responsible for correcting XP-A cellular deficiencies.
Main Methods:
- Purification of protein factors from calf thymus and HeLa cells.
- Microinjection of protein preparations into XP-A cells to assay UV-induced unscheduled DNA synthesis.
- Biochemical characterization including heat stability, SDS/urea treatment, gel filtration, and SDS-PAGE.
- DNA binding assays (Southwestern blots) and immunological assays using antibodies against human XP-A protein.
Main Results:
- A protein factor was purified that restores UV-induced DNA repair in XP-A cells.
- The XP-A correcting protein is highly stable, with a molecular weight of approximately 40-45 kD.
- The purified protein binds to single-stranded DNA and shows cross-reactivity with antibodies against human XP-A protein.
- A specific 41 kD protein band was identified as the active factor, exhibiting both DNA binding and immunological properties.
Conclusions:
- A stable protein factor capable of correcting the excision repair defect in XP-A cells has been identified and partially characterized.
- The purified calf protein shares characteristics with the human XP-A gene product, suggesting evolutionary conservation.
- This factor represents a potential therapeutic target or research tool for understanding and treating XP-A.